Target Gene Table
VIS IDVirusEnsembl IDGene TypeTarget GeneOncogeneTumor Suppressor GeneNCBI IDUniprot ID
TVIS20024814HPVENSG00000153253.20protein_codingSCN3ANoNo6328Q9C007
Q9NY46
TVIS20030919HPVENSG00000153253.20protein_codingSCN3ANoNo6328Q9C007
Q9NY46
TVIS20030920HPVENSG00000153253.20protein_codingSCN3ANoNo6328Q9C007
Q9NY46
TVIS44032001HTLV-1ENSG00000153253.20protein_codingSCN3ANoNo6328Q9C007
Q9NY46
TCGA Plot Options
Drug Information
GeneSCN3A
DrugBank IDDB00909
Drug NameZonisamide
Target IDBE0002082
UniProt IDQ9NY46
Regulation Typeinhibitor
PubMed IDs20025128; 18433351; 20001433; 14704463; 19948168; 15511691; 19557119
CitationsJanszky J: [Role of zonisamid in treating epilepsy, Parkinson disorders and other neurological diseases]. Ideggyogy Sz. 2009 Nov 30;62(11-12):383-9.@@Kothare SV, Kaleyias J: Zonisamide: review of pharmacology, clinical efficacy, tolerability, and safety. Expert Opin Drug Metab Toxicol. 2008 Apr;4(4):493-506. doi: 10.1517/17425255.4.4.493 .@@Schulze-Bonhage A: Zonisamide in the treatment of epilepsy. Expert Opin Pharmacother. 2010 Jan;11(1):115-26. doi: 10.1517/14656560903468728.@@Sobieszek G, Borowicz KK, Kimber-Trojnar Z, Malek R, Piskorska B, Czuczwar SJ: Zonisamide: a new antiepileptic drug. Pol J Pharmacol. 2003 Sep-Oct;55(5):683-9.@@Sonsalla PK, Wong LY, Winnik B, Buckley B: The antiepileptic drug zonisamide inhibits MAO-B and attenuates MPTP toxicity in mice: clinical relevance. Exp Neurol. 2010 Feb;221(2):329-34. doi: 10.1016/j.expneurol.2009.11.018. Epub 2009 Dec 4.@@Leppik IE: Zonisamide: chemistry, mechanism of action, and pharmacokinetics. Seizure. 2004 Dec;13 Suppl 1:S5-9; discussion S10.@@Zaccara G, Specchio LM: Long-term safety and effectiveness of zonisamide in the treatment of epilepsy: a review of the literature. Neuropsychiatr Dis Treat. 2009;5:249-59. Epub 2009 May 20.
GroupsApproved; Investigational
Direct ClassificationBenzisoxazoles
SMILESNS(=O)(=O)CC1=NOC2=CC=CC=C12
Pathways
PharmGKBPA451978
ChEMBLCHEMBL750